| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | R. S. Tuan | |
| W. M. Jackson | |||
| L. J. Nesti | |||
| P2860 | cites work | Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane | Q47778662 |
| Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts | Q47850490 | ||
| Wound therapy by marrow mesenchymal cell transplantation | Q47870926 | ||
| Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type | Q47933679 | ||
| Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. | Q48434572 | ||
| Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds | Q48910075 | ||
| IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. | Q50649901 | ||
| Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. | Q50674319 | ||
| Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
| Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells | Q73099605 | ||
| Participation of bone marrow derived cells in cutaneous wound healing | Q73540069 | ||
| Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway | Q73707566 | ||
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 | ||
| Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury | Q79814259 | ||
| The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities | Q80065296 | ||
| Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells | Q80403767 | ||
| Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries | Q81610505 | ||
| All MSCs are pericytes? | Q81955225 | ||
| Effects of nanofiber/stem cell composite on wound healing in acute full-thickness skin wounds | Q83236419 | ||
| Autologous skin cell spray-transplantation for a deep dermal burn patient in an ambulant treatment room setting | Q83446097 | ||
| Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering | Q84059902 | ||
| Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts | Q84785418 | ||
| Mesenchymal stem cells avoid allogeneic rejection | Q21245658 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Wound healing--aiming for perfect skin regeneration | Q29616715 | ||
| Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
| Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
| Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
| Why are MSCs therapeutic? New data: new insight. | Q33386080 | ||
| Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice | Q33505675 | ||
| Mesenchymal progenitor cells derived from traumatized human muscle | Q33621835 | ||
| Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method | Q34210598 | ||
| Mesenchymal stromal cells: current understanding and clinical status | Q34234464 | ||
| Isolation of amniotic stem cell lines with potential for therapy | Q34598404 | ||
| The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. | Q34645189 | ||
| Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor | Q35009828 | ||
| The wound healing process: an overview of the cellular and molecular mechanisms | Q35014036 | ||
| Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 | ||
| The Hedgehog transcription factor Gli3 modulates angiogenesis | Q35219195 | ||
| Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. | Q35567830 | ||
| Wound healing: an overview of acute, fibrotic and delayed healing | Q35650806 | ||
| Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts | Q35824711 | ||
| Mesenchymal stem cell therapy for attenuation of scar formation during wound healing | Q36084821 | ||
| Adrenomedullin: a protective factor for blood vessels | Q36248641 | ||
| Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair | Q36437461 | ||
| Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes | Q36575450 | ||
| Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature | Q36591314 | ||
| Haemostasis | Q36604077 | ||
| Fibroblasts and myofibroblasts: their source, function and role in disease. | Q36695858 | ||
| Stem cells in the umbilical cord | Q36712808 | ||
| Adipose-derived cells | Q37092184 | ||
| Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue | Q37132476 | ||
| Promotion of incisional wound repair by human mesenchymal stem cell transplantation | Q37147819 | ||
| Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute | Q37185549 | ||
| Growth factors and cytokines in wound healing | Q37364066 | ||
| Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. | Q37386259 | ||
| Mesenchymal stem cells induce dermal fibroblast responses to injury | Q37455880 | ||
| Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. | Q37536886 | ||
| Potential application of adipose-derived stem cells and their secretory factors to skin: discussion from both clinical and industrial viewpoints | Q37706602 | ||
| Topical delivery of mesenchymal stem cells and their function in wounds | Q37791614 | ||
| Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells | Q39753209 | ||
| Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model | Q39804117 | ||
| Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation | Q39856804 | ||
| Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration | Q39928648 | ||
| A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns | Q40168901 | ||
| Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor | Q40251536 | ||
| Interactions between human mesenchymal stem cells and natural killer cells | Q40385365 | ||
| Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. | Q40418033 | ||
| A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition | Q40493463 | ||
| Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis | Q40578343 | ||
| Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. | Q42444492 | ||
| Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism | Q42717964 | ||
| Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism | Q42828277 | ||
| Mesenchymal stem cells' interaction with skin: Wound-healing effect on fibroblast cells and skin tissue | Q42855635 | ||
| Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis | Q45116941 | ||
| Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats | Q45879074 | ||
| Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure | Q46376455 | ||
| Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells | Q46584311 | ||
| Fibroblast differentiation of bone marrow-derived cells during wound repair | Q46598410 | ||
| Diverse and potent activities of HGF/SF in skin wound repair | Q47278753 | ||
| Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. | Q47585368 | ||
| Chemotaxis of human articular chondrocytes and mesenchymal stem cells | Q47722749 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | wound healing | Q1509074 |
| mesenchymal stem cell | Q1922379 | ||
| P304 | page(s) | 44-50 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Stem Cells Translational Medicine | Q26842216 |
| P1476 | title | Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells | |
| P478 | volume | 1 |
| Q37408992 | A Small Chimeric Fibronectin Fragment Accelerates Dermal Wound Repair in Diabetic Mice |
| Q50468347 | A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds. |
| Q58590587 | Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells |
| Q37604291 | Adipocytes in skin health and disease |
| Q39376213 | Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. |
| Q26770234 | Adult Stem Cell Therapies for Wound Healing: Biomaterials and Computational Models |
| Q33624600 | Advances in Skin Regeneration Using Tissue Engineering |
| Q38270139 | Advances in skin grafting and treatment of cutaneous wounds. |
| Q46097026 | Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses. |
| Q55425315 | Allogeneic mesenchymal stem cells improve the wound healing process of sheep skin. |
| Q47226071 | An in vitro skin model to study the effect of mesenchymal stem cells in wound healing and epidermal regeneration |
| Q36387608 | BMP6-Engineered MSCs Induce Vertebral Bone Repair in a Pig Model: A Pilot Study |
| Q58609660 | Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs |
| Q35826470 | Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice |
| Q47720723 | Can regenerative medicine and nanotechnology combine to heal wounds? The search for the ideal wound dressing. |
| Q40880616 | Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype |
| Q38136188 | Cellular kinetics of perivascular MSC precursors. |
| Q98287929 | Characterizing the dynamic rheology in the pericellular region by human mesenchymal stem cell re-engineering in PEG-peptide hydrogel scaffolds |
| Q36702635 | Citrate-Based Biomaterials and Their Applications in Regenerative Engineering |
| Q92823262 | Clumps of Mesenchymal Stem Cell/Extracellular Matrix Complexes Generated with Xeno-Free Conditions Facilitate Bone Regeneration via Direct and Indirect Osteogenesis |
| Q47197583 | Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow |
| Q90049975 | Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes |
| Q26750660 | Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases |
| Q33690017 | Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing |
| Q52644312 | Cryopreserved clumps of mesenchymal stem cell/extracellular matrix complexes retain osteogenic capacity and induce bone regeneration. |
| Q47102946 | Current and Future Perspectives of Stem Cell Therapy in Dermatology. |
| Q27301248 | Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model |
| Q42182391 | Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers. |
| Q37323019 | Diabetic wound regeneration using peptide-modified hydrogels to target re-epithelialization. |
| Q38809114 | Effects of WNT3A and WNT16 on the Osteogenic and Adipogenic Differentiation of Perivascular Stem/Stromal Cells. |
| Q38119878 | Evidence for the use of biological therapies in ulcers of the foot in diabetes |
| Q42592803 | Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs. |
| Q50926145 | Flavonoids of Herba Epimedii stimulate osteogenic differentiation and suppress adipogenic differentiation of primary mesenchymal stem cells via estrogen receptor pathway. |
| Q42039513 | Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
| Q35022647 | Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells |
| Q33954420 | Gr-1+CD11b+ myeloid cells efficiently home to site of injury after intravenous administration and enhance diabetic wound healing by neoangiogenesis |
| Q43103263 | Hepatocyte growth factor-loaded biomaterials for mesenchymal stem cell recruitment |
| Q50472867 | Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. |
| Q90141942 | Human amniotic fluid stem cells have a unique potential to accelerate cutaneous wound healing with reduced fibrotic scarring like a fetus |
| Q51687489 | Hypoxia pretreatment of bone marrow-derived mesenchymal stem cells seeded in a collagen-chitosan sponge scaffold promotes skin wound healing in diabetic rats with hindlimb ischemia. |
| Q92325371 | IL6 Receptor Facilitates Adipogenesis Differentiation of Human Mesenchymal Stem Cells through Activating P38 Pathway |
| Q29994669 | Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy |
| Q42001107 | In Vitro Evaluation of Scaffolds for the Delivery of Mesenchymal Stem Cells to Wounds |
| Q34293509 | In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs |
| Q89433941 | Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model |
| Q26771918 | Insight into Reepithelialization: How Do Mesenchymal Stem Cells Perform? |
| Q52936398 | Intermittent cycles of remote ischemic preconditioning augment diabetic foot ulcer healing. |
| Q64893939 | Intratunical Injection of Human Adipose Tissue-Derived Stem Cells Restores Collagen III/I Ratio in a Rat Model of Chronic Peyronie's Disease. |
| Q33657972 | Isolation and characterization of canine perivascular stem/stromal cells for bone tissue engineering. |
| Q52921412 | Local application of adipose-derived mesenchymal stem cells supports the healing of fistula: prospective randomised study on rat model of fistulising Crohn's disease. |
| Q27320302 | Membrane Blebbing Is Required for Mesenchymal Precursor Migration |
| Q28260373 | Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro |
| Q64234930 | Mesenchymal Stem Cells Coated by the Extracellular Matrix Promote Wound Healing in Diabetic Rats |
| Q39271587 | Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages. |
| Q39100850 | Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging |
| Q36084821 | Mesenchymal stem cell therapy for attenuation of scar formation during wound healing |
| Q46761512 | Mesenchymal stem cell-conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment |
| Q38197918 | Mesenchymal stem cells for chronic wounds therapy. |
| Q36235785 | Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress |
| Q35685469 | Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting. |
| Q38790866 | MiR-144-3p regulates osteogenic differentiation and proliferation of murine mesenchymal stem cells by specifically targeting Smad4. |
| Q38253187 | MicroRNAs are potential prognostic and therapeutic targets in diabetic osteoarthritis |
| Q38153432 | Microdeformation in wound healing |
| Q28392792 | Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro |
| Q92017489 | Modeling appendicular skeletal cartilage development with modified high-density micromass cultures of adult human bone marrow-derived mesenchymal progenitor cells |
| Q36512553 | Neuropeptide Substance-P-Conjugated Chitosan Nanofibers as an Active Modulator of Stem Cell Recruiting |
| Q38114433 | Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers |
| Q35656274 | Purified Human Synovium Mesenchymal Stem Cells as a Good Resource for Cartilage Regeneration |
| Q90274779 | Rapid Bioorthogonal Chemistry Enables in Situ Modulation of the Stem Cell Behavior in 3D without External Triggers |
| Q38682362 | Recent advances in electrospun nanofibers for wound healing |
| Q89950834 | Regenerative Potential of Menstrual Blood-Derived Stem Cells and Platelet-Derived Growth Factor in Endometrial Injury |
| Q38177814 | Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation. |
| Q38162434 | Review: mesenchymal stem cells and corneal reconstruction |
| Q88395107 | Rheological characterization of dynamic remodeling of the pericellular region by human mesenchymal stem cell-secreted enzymes in well-defined synthetic hydrogel scaffolds |
| Q26748513 | Stem Cells in Skin Wound Healing: Are We There Yet? |
| Q50216598 | Stimulation of Osteogenic Differentiation by Saikosaponin-A in Bone Marrow Stromal Cells Via WNT/β-Catenin Pathway |
| Q38745994 | Stingless Bee Honey, the Natural Wound Healer: A Review |
| Q38253203 | Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease. |
| Q89115946 | Substrate micropatterns produced by polymer demixing regulate focal adhesions, actin anisotropy, and lineage differentiation of stem cells |
| Q33812106 | Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms |
| Q38078558 | Surgical inflammatory stress: the embryo takes hold of the reins again. |
| Q37736124 | TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed. |
| Q37348530 | The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential |
| Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
| Q37216855 | Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds |
| Q34089606 | Tissue engineering and regenerative repair in wound healing. |
| Q35564720 | Transdifferentiation of Umbilical Cord-Derived Mesenchymal Stem Cells Into Epidermal-Like Cells by the Mimicking Skin Microenvironment |
| Q90747120 | Treatment of Full-Thickness Skin Wounds with Blood-Derived CD34+ Precursor Cells Enhances Healing with Hair Follicle Regeneration |
Search more.